{"entity":{"id":"paper-bray-globocan-2018-cacancer-2018","kind":"paper","name":"Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers","aka":[],"tldr":"The IARC count for 2018: about 18.1 million new cancer cases worldwide, with lung cancer the most commonly diagnosed and most lethal, and about one in five men and one in six women developing cancer during their lifetime.","summary":"GLOBOCAN 2018 estimated cancer incidence and mortality for 36 cancers in 185 countries from national and regional registries and modelling. It counted 18.1 million new cases in 2018. Lung cancer was the most commonly diagnosed cancer and the leading cause of cancer death, followed for incidence by female breast, colorectal and prostate cancers. The report described how cancer patterns differ with a country's level of development, with infection-related cancers of the cervix, liver and stomach concentrated in transitioning economies.","asOf":"2026-09-08","links":[{"label":"Full text (DOI)","url":"https://doi.org/10.3322/caac.21492"},{"label":"IARC Global Cancer Observatory","url":"https://gco.iarc.who.int/today"}],"tags":[],"related":["paper-sung-globocan-2020-cacancer-2021","paper-bray-globocan-2022-cacancer-2024"],"cancers":["nsclc","breast-hr-positive","colorectal","prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["iarc"],"pathways":[],"terms":["incidence-vs-prevalence","mortality"],"trials":[],"people":["bray-freddie"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"CA: A Cancer Journal for Clinicians","year":2018,"doi":"10.3322/caac.21492","authors":"Bray F, Ferlay J, Soerjomataram I, et al.","paperType":"observational","findings":["About 18.1 million new cancer cases and 9.6 million cancer deaths worldwide in 2018.","Lung cancer the most commonly diagnosed (11.6% of cases) and the leading cause of cancer death (18.4% of deaths); female breast cancer also 11.6% of cases; colorectal 10.2%; prostate 7.1%.","About one in five men and one in six women develop cancer during their lifetime; one in eight men and one in eleven women die from it."],"whatItMeans":"This was the most cited description of the global cancer burden until the 2020 release and is the reference behind many national cancer plans of the late 2010s. Its country-level comparisons showed where prevention, such as HPV and hepatitis B vaccination and tobacco control, would have the largest effect.","caveats":["Registry coverage is incomplete in much of Africa and Asia, so those estimates depend on modelling.","Superseded by the 2020 and 2022 releases."],"changedPractice":false},"route":"/key-papers/paper-bray-globocan-2018-cacancer-2018/","neighbours":{"paper":[{"id":"paper-allemani-concord-3-lancet-2018","kind":"paper","name":"Allemani 2018: CONCORD-3, global surveillance of cancer survival 2000 to 2014","route":"/key-papers/paper-allemani-concord-3-lancet-2018/"},{"id":"paper-bray-globocan-2022-cacancer-2024","kind":"paper","name":"Bray 2024: GLOBOCAN 2022, the world's cancer count for 36 cancers in 185 countries","route":"/key-papers/paper-bray-globocan-2022-cacancer-2024/"},{"id":"paper-chen-cancer-statistics-china-2015-cacancer-2016","kind":"paper","name":"Chen 2016: Cancer statistics in China, 2015","route":"/key-papers/paper-chen-cancer-statistics-china-2015-cacancer-2016/"},{"id":"paper-ferlay-globocan-2018-methods-ijc-2019","kind":"paper","name":"Ferlay 2019: GLOBOCAN 2018 sources and methods","route":"/key-papers/paper-ferlay-globocan-2018-methods-ijc-2019/"},{"id":"paper-fitzmaurice-gbd-cancer-2015-jamaoncol-2017","kind":"paper","name":"Fitzmaurice 2017: the Global Burden of Disease estimate of cancer in 2015","route":"/key-papers/paper-fitzmaurice-gbd-cancer-2015-jamaoncol-2017/"},{"id":"paper-sung-globocan-2020-cacancer-2021","kind":"paper","name":"Sung 2021: GLOBOCAN 2020, the year breast cancer overtook lung cancer as the most diagnosed cancer","route":"/key-papers/paper-sung-globocan-2020-cacancer-2021/"},{"id":"paper-torre-global-cancer-statistics-2012-cacancer-2015","kind":"paper","name":"Torre 2015: Global cancer statistics, 2012","route":"/key-papers/paper-torre-global-cancer-statistics-2012-cacancer-2015/"}],"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"institution":[{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"}],"term":[{"id":"incidence-vs-prevalence","kind":"term","name":"Incidence versus prevalence","route":"/terms/incidence-vs-prevalence/"},{"id":"mortality","kind":"term","name":"Mortality","route":"/terms/mortality/"}],"person":[{"id":"bray-freddie","kind":"person","name":"Freddie Bray","route":"/people/bray-freddie/"}]}}